Allogene Therapeutics, Inc. (ALLO) Technical Analysis
$2.10
Insights
- Allogene Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Allogene Therapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Allogene Therapeutics stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Allogene Therapeutics stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 65.3 | Sell |
Stochastic | 40.43, 71.01 | Neutral |
Ultimate Oscillator | 32.6 | Neutral |
Stochastic Relative Strength Index | 86.33, 90.88 | Sell |
Moving Average Convergence Divergence | 0.16, 0.11 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.63 | Buy |
20 | 2.46 | Buy |
50 | 2.28 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.69 | Buy |
20 | 2.55 | Buy |
50 | 2.29 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.22 | Sell |
20 | 2.88 | Sell |
50 | 2.53 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.87 | Buy |
20 | 2.75 | Buy |
50 | 2.66 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.96 | Buy |
20 | 2.8 | Buy |
50 | 2.75 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 3.25 |
Resistance L2 | 3.1 |
Resistance L1 | 2.91 |
Pivot Point | 2.76 |
Support L1 | 2.57 |
Support L2 | 2.42 |
Support L3 | 2.23 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.